Chimeric antigen receptor (CAR) T cell therapy has shown remarkable therapeutic efficacy against hematological malignancies, but it has not translated into the treatment against solid tumors. The major challenges include: 1) accessibility of tumor specific antigens that will minimize on-target off-t
Sci. Transl. Med.2020-09-24
![[CN Bio / Fluigent / 신코] Organ on a Chip 플랫폼 & ICP 등 바이오 연구장비 라인업](/app/board/attach/image/1348946_1772523445000.do?)
![[에펜도르프] 2026 상반기 특별 프로모션 : 프리미엄 에펜도르프 제품을 좋은 혜택으로 만날 수 있는 기회!](/app/board/attach/image/1348816_1772455401000.do?)
